Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...
Etavopivat improved hemoglobin levels and reduced pain crises in a Phase 3 sickle cell disease trial, supporting potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results